TY - JOUR
T1 - The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders
T2 - A HuGE review and meta-analysis of evidence from observational studies
AU - Dennis, Jessica
AU - Johnson, Candice Y.
AU - Adediran, Adeniyi Samuel
AU - De Andrade, Mariza
AU - Heit, John A.
AU - Morange, Pierre Emmanuel
AU - Trégouët, David Alexandre
AU - Gagnon, France
PY - 2012/3/8
Y1 - 2012/3/8
N2 - The endothelial protein C receptor (EPCR) limits thrombus formation by enhancing activation of the protein C anticoagulant pathway, and therefore may play a role in the etiology of thrombotic disorders. The rs867186 single-nucleotide polymorphism in the PROCR gene (g.6936A > G, c.4600A > G), resulting in a serine-to-glycine substitution at codon 219, has been associated with reduced activation of the protein C pathway, although its association with thrombosis risk remains unclear. The present study is a highly comprehensive systematic review and meta-analysis, including unpublished genome-wide association study results, conducted to evaluate the evidence for an association between rs867186 and 2 common thrombotic outcomes, venous thromboembolism (VTE) and myocardial infarction (MI), which are hypothesized to share some etiologic pathways. MEDLINE, EMBASE, and HuGE Navigator were searched through July 2011 to identify relevant epidemiologic studies, and data were summarized using random-effects meta-analysis. Twelve candidate genes and 13 genome-wide association studies were analyzed (11 VTE and 14 MI, including 37 415 cases and 84 406 noncases). Under the additive genetic model, the odds of VTE increased by a factor of 1.22 (95% confidence interval, 1.11-1.33, P < .001) for every additional copy of the G allele. No evidence for association with MI was observed.
AB - The endothelial protein C receptor (EPCR) limits thrombus formation by enhancing activation of the protein C anticoagulant pathway, and therefore may play a role in the etiology of thrombotic disorders. The rs867186 single-nucleotide polymorphism in the PROCR gene (g.6936A > G, c.4600A > G), resulting in a serine-to-glycine substitution at codon 219, has been associated with reduced activation of the protein C pathway, although its association with thrombosis risk remains unclear. The present study is a highly comprehensive systematic review and meta-analysis, including unpublished genome-wide association study results, conducted to evaluate the evidence for an association between rs867186 and 2 common thrombotic outcomes, venous thromboembolism (VTE) and myocardial infarction (MI), which are hypothesized to share some etiologic pathways. MEDLINE, EMBASE, and HuGE Navigator were searched through July 2011 to identify relevant epidemiologic studies, and data were summarized using random-effects meta-analysis. Twelve candidate genes and 13 genome-wide association studies were analyzed (11 VTE and 14 MI, including 37 415 cases and 84 406 noncases). Under the additive genetic model, the odds of VTE increased by a factor of 1.22 (95% confidence interval, 1.11-1.33, P < .001) for every additional copy of the G allele. No evidence for association with MI was observed.
UR - http://www.scopus.com/inward/record.url?scp=84863419775&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863419775&partnerID=8YFLogxK
U2 - 10.1182/blood-2011-10-383448
DO - 10.1182/blood-2011-10-383448
M3 - Article
C2 - 22251481
AN - SCOPUS:84863419775
SN - 0006-4971
VL - 119
SP - 2392
EP - 2400
JO - Blood
JF - Blood
IS - 10
ER -